CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-30 | White Lauren Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-30 | Boyle Scott N Chief Business Officer | Option exercise | +3,750 | 6,398 | ||
| 2023-01-30 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −1,222 | $7.78 | $10K | 5,176 |
| 2023-01-30 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-30 | Hirsch Andrew President & CEO | Option exercise | +12,500 | 31,325 | ||
| 2023-01-30 | Hirsch Andrew President & CEO | Shares withheld for taxes | −4,319 | $7.78 | $34K | 27,006 |
| 2023-01-30 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −12,500 | 62,500 | ||
| 2023-01-30 | Schick Kelly Chief People Officer | Option exercise | +3,750 | 6,398 | ||
| 2023-01-30 | Schick Kelly Chief People Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 5,097 |
| 2023-01-30 | Schick Kelly Chief People Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-30 | Siegel Jolie Chief Legal Officer | Option exercise | +3,750 | 6,398 | ||
| 2023-01-30 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 5,097 |
| 2023-01-30 | Siegel Jolie Chief Legal Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Option exercise | +3,750 | 77,788 | ||
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 76,487 |
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-06 | Anderson Kenneth Carl Director | Option exercise | +268 | $2.11 | $565 | 94,684 |
| 2023-01-06 | Anderson Kenneth Carl Director | Option exercise | +444 | $4.98 | $2K | 95,128 |
| 2023-01-06 | Anderson Kenneth Carl Director | Option exercise · Stock Option (Right to Buy) | −268 | 1,067 | ||
| 2023-01-06 | Anderson Kenneth Carl Director | Option exercise · Stock Option (Right to Buy) | −444 | 890 |
Page 14 of 27 · 525 trades